ipilimumab
bms
['ipilimumab', 'melanoma']
tumor-infiltrating lymphocytes outperform ipilimumab in advanced melanoma 
UPDATE~ I am a stage 4 melanoma survivor who was diagnosed in 1995 at age 25. Thanks to a phase 1 clinical trial in 2011. Sharing Melanoma Awareness.